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NICE and its value judgments
Option of safe “understudy” treatments
should be available
Editor—The National Institute for Clinical
Excellence (NICE) aims for the highest
attainable standards of care.1 The bedrock of
its advice is published evidence of benefits
from treatment (mainly pharmaceuticals).
In the report accepted in May considera-
tion of safety issues focused on invasive sur-
gical and diagnostic procedures, and the
“judgment” on risk assumed that such risks
are small and calculable.2 In economic
terms, to distinguish between real risk
(calculable and potentially manageable) and
uncertainty, where judgment of costs is
purely subjective, is important.
In July the new health service director of
research and development announced a
forthcoming national programme of
research on drug treatment in children.
Given the serious and quite common
adverse consequences of paediatric treat-
ment reported,3 a fundamental reassessment
of child health interventions is warranted.
Adverse drug reactions or interactions
between new and existing drug treatments
are uncertain in caring for children aged
0-16 years. NICE has hitherto sought to
judge the best treatment (singular), but in an
uncertain interaction between doctor and
child simultaneous identification of “good
enough” second line treatments that can
understudy for the “best” treatment when
the safety of an individual child may
preclude using the most cost effective drug
may make good economic sense. This “good
enough for some children” standard is not
currently in the expertise of the licensing
authorities, but it could become a feature of
NICE expertise.
In the absence of safe treatment alterna-
tives, the long term costs to some children
and families (and the health service) of
adverse drug reactions could be heavy. For
adult health care the burden of adverse drug
reactions is 6.5% of hospital admissions.4 For
childhood drug treatment, what will be our
options?
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Utilitarian values are inadequate
Editor—The values of the National Institute
for Clinical Excellence (NICE) turn out to be
utilitarian and economic.1 Predictably,
NICE’s attempt to use them to generate
advice to professionals for achieving the
highest attainable standard of care often
founders on the narrowness of perspective.
High quality care demands an understand-
ing of human suffering that transcends the
urge to fix biological machine faults.
Take obesity. In 2001 NICE approved
the prescription of orlistat and sibutramine
to obese patients, a tiresome diversion in the
face of a developed world pandemic of
obesity. Obesity is about consumption, and
consumption is woven into the fabric of
society. No amount of medical technology or
guidelines stands any meaningful chance of
changing this. The problem is cultural, and
the solutions are political and educational.
We might be spared these distractions if
NICE added two new questions to their
appraisals.
Firstly, is the problem for which the
technology is intended best dealt with by a
medical approach delivered in the NHS?
Secondly, would receiving the technol-
ogy be likely to benefit the health (broadly
defined) of the individual patient?
These questions demand values that
clarify the purpose of the NHS and the
nature of health. They must recognise that
illness occurs in a network of relationships:
with ourselves, society, and nature. The diffi-
culty here reflects what MacIntyre calls the
grave disorder in the language of morality.2
But we must try, or accept that medicine will
choke on its own trivial non-solutions for
enormous problems.
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Favourable appraisal amounts to
compulsory purchase order
Editor—The role of the National Institute
for Clinical Excellence (NICE) in reducing
the postcode lottery is limited by the denial
of its legitimate role in healthcare ration-
ing.1 2 The focus on new and expensive
drugs, and the requirement by the govern-
ment that NHS bodies implement NICE
guidance within three months, seriously
skew local priorities.
The use of sales data to monitor the
uptake of a NICE approved drug militates
against an orderly and considered uptake of
new technologies. A favourable NICE
appraisal amounts to a compulsory pur-
chase order. The agenda is therefore set not
by NICE but by those who apply to NICE for
their products to be appraised.
The reason why NICE has not appraised
yoga or transcendental meditation for stress
and hypertension, or a lifestyle intervention
involving 3-4 kg weight loss and 150
minutes of moderately vigorous physical
activity a week as a “technology” that cuts the
risk of overt diabetes by 50% is obvious. It
would have been interesting to see how the
implementation of such technologies would
have been enforced.
The excessive focus on drug treatments
also ignores the real postcode lottery of
life—a lottery that applies far more to the
determinants of health (housing, education,
job opportunities, healthy food) than to
health care. The mandatory requirement to
implement expensive and marginally effec-
tive NICE appraised treatments means that
we in the NHS have less time and no resource
to devote to other public health interventions
that may well yield a far bigger health
dividend for a larger number of people.
Jammi N Rao director of public health
North Birmingham Primary Care Trust,
Birmingham B44 8BH
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Authors’ reply
Editor—Caan may be right about second
line treatments, but the point applies to
more than just paediatric prescribing. Fortu-
nately, there is nothing in NICE’s current
appraisal methods to exclude these consid-
erations,1 and we have already done so on
several occasions.
House and Peters are wrong to call
NICE’s values utilitarian, but they are
certainly consequentialist. By this we mean
that NICE evaluates the likely consequences
of using the technologies; this is certainly
economic in trying to quantify conse-
quences, being explicit about the value judg-
ments involved, and taking account of the
NHS resources that will be used. Whether
health is better promoted by means beyond
the NHS is pertinent, although it not a ques-
tion NICE has been charged with answering.
We have much sympathy with what
elsewhere is called the population health
approach. From next April, guidance on pub-
lic health will form part of NICE’s portfolio.
Rao also supports this approach but does not
approve of the selection of technologies we
review. Topics are selected by ministers after
widespread consultation, and they are
certainly not set by manufacturers.
We think it inevitable that any attempt to
create fairness in access to medicines in
England and Wales is bound to compromise
some “local priorities.” But it was, of course,
differing “local priorities” that created the
postcode prescribing in the first place, and
the public will not tolerate its re-emergence.
We readily concede that NICE’s recommen-
dations entail difficult choices about
resource allocation, but we emphasise that
no local decisions about allocation of
resources are subjected to anything
approaching the rigour of NICE’s approach
to cost effectiveness. Neither is there any dis-
tant analogy between our procedures and
wartime “rationing,” which both of us vividly
remember.
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The evidence base for shaken
baby syndrome
Meaning of signature must be made
explicit
Editor—Reece et al’s response to the edito-
rial of Geddes and Plunkett claims to be a
response of “106 doctors.”1 2 What, precisely,
do the 106 signatures attached to this letter
signify? That all had reviewed the letter and
were in full agreement with the entire
content? That they agreed in general with
the thrust of the letter? Or was this more a
show of solidarity on the part of doctors
who care deeply about the risks of shaking
on children?
This needs clarification if the signatures
are to carry any weight what-
soever. Science—even medi-
cal science—is not a popular-
ity contest. The meaning of a
signature must be made
explicit for it to add weight
to a document.
Each signature carries
with it responsibilities of
authorship. Reece’s letter
declared no competing
interests, but all signatories
would need to comply for
this to be true.
Six of the signatories
(Levin, Chadwick, Alexander,
Barr, Jenny, and Reece) are
medical practitioners on the International
Advisory Board of the National Center on
Shaken Baby Syndrome (www.
dontshake.com). They participate in this
group’s conferences and are presumably
compensated or reimbursed for this work—
information requiring disclosure under BMJ
guidelines.
The letter of Reece exemplifies a
problem identified in my own paper3—that
the literature on shaken baby syndrome is
polarised and based more on strong beliefs
and opinions than strong data. Ten thou-
sand signatures cannot change this.4
Mark Donohoe general practitioner
Mosman, NSW 2088, Australia
drmark@bigpond.net.au
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Competing interest declaration of the 106
authors and an editorial explanation
Editor—The BMJ asked my co-authors and
me to complete a competing interests form
only after our letter was published.1 2
Competing interest declaration:Many of
the letter’s authors practise, teach, lecture,
consult, and do research on matters
involving child abuse, including shaken baby
syndrome. Some lecturers receive honorari-
ums for their lectures, many of which are
given to the lecturer’s institution.
Some receive research funding for a
variety of projects. Many have testified in
civil and criminal courts, having been called
in the main, though not exclusively, by
departments of social services, families,
prosecution, and defence. They are gener-
ally paid for their time.
Some serve on non-profit boards of
organisations with concerns about child
maltreatment, including shaken baby syn-
drome, and are not compensated for this
service.
Robert M Reece clinical professor of paediatrics
PO Box 523, 122 Hawk Pine Road, Norwich, VT
05055, USA
rmreece1.aol.com
*** It is our policy to obtain a
competing interest declara-
tion before publication. In
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occurred because Professor
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and our checking mecha-
nisms failed—editor
1 Reece RM. The evidence base for
shaken baby syndrome. BMJ
2004;328:1316-7. (29 May.)
2 BMJ declaration of competing inter-




Response to Reece et al from 41
physicians and scientists
Editor—Reece et al have implied that child
abuse is a particularly difficult area in which
to conduct research.1 This difficulty does not
justify circular reasoning, selection bias,
imprecise case definition, unsystematic
review publications, or conclusions that
overstep the data.2–5 w1-w3
Geddes and Plunkett described the use
of evidence based medicine in evaluating
the causes of head injury in infants and
children.w4 w5 Evidence based medicine is the
conscientious, explicit, and judicious use of
scientific evidence in making medical deci-
sions and cautions against unsystematic,
untested reasoning and intuition based
clinical applications. It integrates scientific
principles and clinical experience with valid,
current research.w6
While much of clinical medicine still
relies on observation, it is critical that these
observations are verified and validated.Often,
the clinician must be more deliberate than
the experimentalist who uses a planned
systematic approach. The clinical researcher
may have to await the natural sequence of
events—deducing relationships that lie below
observed phenomenon, being more logical
and less dogmatic, and avoiding the fallacy of
mistaking correlation with causation.w7 If the
principles of science and evidence based
medicine are not critically applied to observa-
tional studies, a set of formulated beliefs
among like-minded people may be re-
inforced, leading to misconceptions and mis-
interpretations. When this occurs, the pri-
mary principle of medicine—first, do no
harm—may be violated.
Child abuse in any form is always unac-
ceptable. However, if errors in diagnosis,
false accusations, and wrongful convictions
result from untested and unverified beliefs,
then we have done harm.
Critically evaluating one’s own under-
standing is far more constructive than
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criticism of those who differ. If we can
approach differences objectively and resolve
them with rational analysis, then we have
moved decisively towards answering difficult
questions.
Patrick E Lantz forensic pathologist
Wake Forest University Health Sciences,
Winston-Salem, NC 27157, USA
plantz@wfubmc.edu
This letter is signed by another 40 physicians and
scientists (see bmj.com for details).
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Population mobility must be considered
Editor—Adams et al highlight the impor-
tance of pre-departure and migration
history in post-immigration refugee medi-
cine,1 but health professionals must also
consider the ongoing reality of mobility in
this population.2
For example, a newcomer, in whom dia-
betes has been diagnosed during screening,
happens to mention the recent death of her
mother. This leads to the discovery of plans
to travel back home to the Sudan and a
timely provision of health advice, malaria
prophylaxis, and a summary of drug
treatment.
Population mobility in the context of
refugees refers to the forced movement of
people beginning before departure and con-
tinuing for years, sometimes a lifetime, as
people search for a place to call home.
Historically, refugee programmes have
focused only on early integration: screening
and disease treatment. Refugees will often
continue to move as they seek community
support and employment, and they will often
return to home (or near to home) countries
to visit friends and relatives.
These movements unveil global health
disparities related to diseases and access to
health care—for example, immigrants are at
increased risk of travel related illness.3 Immi-
grants are often unaware of the importance
of travel advice and disease prevention strat-
egies. Acknowledging the reality of this
mobility can allow for a systematic delivery
of advice on travelling home, health promo-
tion for cancers and cardiovascular diseases,4
and low cost mechanisms to communicate
and transfer medical histories.
Kevin Pottie assistant professor
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Children’s needs should not be seen in
isolation
Editor—Adams et al discussed the chal-
lenges of post-immigrant refugee medicine.1
The physical and mental health needs of
refugee children are unique. Children
comprise nearly half of the refugee popula-
tion in many countries and may arrive mal-
nourished without any screening or immu-
nisation. They need culturally sensitive
dietary advice and information about sexual
habits and avoiding drugs.
Despite increasing focus on the mental
health of refugee children, research data are
lacking.2 Some researchers have found an
increased risk of post-traumatic stress disor-
der, depression, and anxiety.3 Others found
no differences between the incidence of psy-
chiatric disorders in refugee children and
the local population.4 Whether this reflects
better assimilation of these children into the
society or unknown variables remains to be
explored.
Children are worried not just about
health but about loss of family members,
loneliness, feeling cold, being depressed,
lack of money, being bullied, language barri-
ers, and being used as interpreters for their
parents.5 They may not seek care for legal
reasons or fear of persecution.
Doctors need training in interviewing
skills that explore these unique issues and
awareness of locally available resources to
act as advocates on their behalf. Collabora-
tion between doctors and mental health,
social, and education services is required.
Children’s needs should not be seen in
isolation but in the context of their families.
The best way to help them is to help their
families. A timely understanding of these
needs will be critical in safeguarding our
future.
Sonal Singh resident physician
1555 Long Pond Road, Department of Medicine,
Unity Health System, Rochester, NY 14626, USA
ssingh@unityhealth.org
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Millennium development goals:
whose goals and for whom?
Editor—Millennium development goals are
the most recent statement of commitment
towards narrowing gaps between the devel-
oped and developing regions of the world.1
But how realistic are these goals?
Although goals help in making assess-
ments of progress, they should not be blind
to existing potentials for progress, which is
conditioned by the existing status as well as
the motivation of nations and states towards
realising them. Unfortunately, millennium
development goals are considered to be a
tool for assessing accountability and high-
light a need for urgency that could violate
the autonomy of nations and states. This
raises the question of whose goals they are.
Often such initiatives are seen as global
priorities, overriding local concerns. The
best example is the vaccination initiative,
which has consistently reflected failures by
countries without the required infrastruc-
ture. In other circumstances, such externally
aided initiatives are never integrated into the
local health system to make the most of such
intervention. In terms of measuring the
extent of achievement of such goals, caution
is advised in assessing progress conditioned
by local realities that may not always be
conducive to making the expected progress.
Finally, who benefits from the achieve-
ment of such goals needs to be made clear.
Would there be any space to account for
inequities resulting in achievement of such
goals? If yes, the assessment of progress in
achieving these goals needs to make adjust-
ments for this to have a realistic evaluation
of progress.
Udaya S Mishra Takemi fellow
Department of Population and International
Health, Harvard School of Public Health, 665,
Huntington Avenue, Boston MA 02115, USA
umishra@hsph.harvard.edu
Competing interests: None declared.
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Women in medicine
Doctors of both sexes are seeking balance
between life and work
Editor—The Medical Women’s Federation
supports Heath’s statement in her editorial
that all occupations should seek to mirror
the demography of society.1 Child care sup-
port at levels found in Scandinavian
countries would greatly support women in
medicine to achieve their potential. How-
Details of the other 40 signatories and all
competing interests are available on
bmj.com, as are references w1-7.
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ever, access to flexible training at specialist
registrar level, which is highly variable by
region and speciality, needs to be improved.2
Many female doctors (and their male
partners, many of whom are also doctors)
have or wish to have families, and hours of
work and working conditions are a key
factor in the career choices made by young
doctors.3 Career paths for men and women
doctors must allow for flexibility in the early
years for a less than 24 hour commitment to
medicine. Young children grow up rapidly,
and in a working life of 40 years women
doctors can easily achieve and function
effectively in top posts and professional
activities, provided that they are supported
during this critical time. We cannot afford to
squander the passion, commitment, and
intelligence of young doctors by not provid-
ing this flexibility at critical times for both
parents. Doctors of both sexes are looking
for a better balance between work and life.4
We have moved beyond the world where
women could have a career in medicine only
by sacrificing family and children on the altar
of ambition. Women doctors want successful
medical careers and a family life, and a social
climate where childcare is shared with the
father, and they are showing it can be done.
Above all we want expert medical practi-
tioners, exercising their professional talents
for the enhancement of society’s health at all
levels. We need to address the real issues in
medicine, those of equity in amodern Britain.
S F Gray president
Medical Women’s Federation, MWF Central Office,
London WC1H 9HX
selena.gray@uwe.ac.uk
Competing interests: SFG is the president of
MWF, a charity which aims to advance the
personal and professional development of
women in medicine.
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Women do not have to choose
Editor—Heath’s editorial on the increasing
number of women in medicine and the
resulting loss in status and influence of the
profession was disappointing.1 She says that
the hourly earnings of male and female doc-
tors are very different. This is not surprising,
given the higher percentage of men
currently in senior positions. Are the hourly
earnings of male and female senior house
officers, registrars, and new consultants
different? The answer is obviously no. The
number of female consultants has risen by
more than 50% in the past 10 years and is
set to continue to do so.
What is the logic in saying that a
feminised profession loses status and
influence? We cannot compare ourselves
with totalitarian societies such as the Soviet
Union. Women do not have to choose
between personal commitments and pro-
fessional power. In a working life of 40
years, it is not a matter of great importance
for a woman to spend a few years working
less than full time for family reasons.
Women are able to reach the top of the pro-
fession, given the right structures and the
removal of discriminatory practices and
sexist attitudes.
Clarissa Fabre honorary secretary
Medical Women’s Federation, London WC1H 9HX
cdfabre@yahoo.co.uk
Competing interests: None declared.
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Sexism is not only reason for women’s
“unequal status” in the workplace
Editor—Heath expresses many misconcep-
tions about women in the workplace.1
Women are compelled to look after their
children, work part time, earn less money,
and do different jobs from men. Better state
support for childrearing, she implies, would
produce equality in the workplace.
Many legitimate factors cause sex differ-
ences in earnings and occupations. Women
earn less because they work fewer hours,
have less experience, work in less-risky jobs,
have more career interruptions, and attach
less weight to salary. Different interests lead
men and women to select different jobs.2
Heath complains that men abandon
occupations when women enter them. How-
ever, changes in occupations
themselves may be responsi-
ble. In the United States,
pharmacy has become
increasingly female, not
because women make the
profession less attractive to
men but because the profes-
sion consists decreasingly of
owners of small businesses
and increasingly of employ-
ees of chain stores.3 Men
tend to favour the autonomy and entrepre-
neurship of business ownership, whereas
women like the lower risk and flexibility of
employment.
Many mothers do not want to work when
their children are young, and many women
prefer to work part time.4 Like women, men
must choose between personal commitments
and professional power, but men are more
inclined to choose professional power.
Family policies will not necessarily have
the desired effect. Policies facilitating child-
bearing often increase fertility,5 which may
attenuate women’s workplace attachment.
Increasing the proportion of the population
employed in childcare would likely increase
occupational segregation, as in Sweden,
because women fill most childcare jobs.
Heath’s goal—parity of wages and
occupations to afford genuine choice—
contradicts itself. For both biological and
social reasons, men and women have differ-
ent preferences. When they act on their
preferences, they choose differently. Only by
constraining preferences—the antithesis of
affording “genuine choice”—can workplace
outcomes be rendered identical.
Kingsley R Browne law professor
Wayne State University Law School, Detroit, MI
48202, USA
Kingsley.browne@wayne.edu
Competing interests: None declared.
1 Heath I. Women in medicine: continuing unequal status of
women may reduce the influence of the profession. BMJ
2004;329:412-3. (21 August.)
2 Browne K.Biology at work: rethinking sexual equality. Rutgers
University Press, 2002.
3 Betz M, O’Connell L. Gender and work: a look at sex
differences among pharmacy students.Am J Pharmacy Educ
1987;51:39-43.
4 Hakim C. Five feminist myths about women’s employment.
Br J Sociol 1995;46:429-55.
5 Zhang J, Quan J, Van Meerbergen P. The effect of
tax-transfer policies on fertility in Canada, 1921-88. J Hum
Resources 1994;29:181-201.
Status cannot be the driver
Editor—With reference to Heath’s editorial
on women in medicine,1 what does “status”
mean and how relevant is it to those of us
deemed to be in “low” status work, such as
family practice?
Simply to express status in terms that are
measurable, such as pay, job position, and
head counts, does not address the real
themes, which are personal and professional
contentment. The eroding social status of
doctors should be viewed positively for
professional vanity has divided the profession
and alienated patients. The influx of people
from lower social classes and of women has
done much to break the old hierarchy and
the destructive “status culture”
over the past 30 years. Status is
an individual perspective and
should never be confused
with mere “position.” Child-
care, also, is not a panacea to
reach professional equality,
and many doctors positively
choose to parent their own
children. The impact of these
commitments long outlasts
the grey flaking portraits that
hang in the royal colleges.
To reach true equality lies paradoxically
by challenging the largely unresearched
gender role of men in society. Are men card-
board cut out figures: inarticulate, cold,
aggressive, uncaring, incapable of loving or
caring for their children? Is it time men be
allowed and encouraged to emulate wom-
en’s dual role? For this to happen, however,
society and the profession need to tackle the
“stereotype” of maleness and ditch some of
the outdated assumptions that gender is a
one way street.
Finally, women have helped “humanise”
the medical profession. We should strive to
have a profession dominated by doctors
who care and not encourage more self
obsessed and status driven applicants.
Des Spence general practitioner
Glasgow G20 9DR
destwo@yahoo.co.uk
Competing interests: None declared.
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